JPY 100.0
(-1.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 259.54 Million | 463.69 Million | 176.15 Million | 244.21 Million | 160.57 Million | 418.11 Million |
Net Income | 158.73 Million | 435.92 Million | 502.98 Million | 239.45 Million | 219.04 Million | 330.97 Million |
Depreciation & Amortization | 302.7 Million | 311.99 Million | 327.51 Million | 335.09 Million | 275.03 Million | 308.74 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -126.56 Million | -176.75 Million | -545.89 Million | -310.31 Million | -288.03 Million | -191.96 Million |
Other non-cash items | 813.34 Million | -107.46 Million | -108.44 Million | -20.02 Million | -45.46 Million | -29.64 Million |
Investing Cash Flow | -80.74 Million | -329.76 Million | -243.58 Million | -572.14 Million | -175.17 Million | -489.81 Million |
Investments in PPE | -132.4 Million | -320.33 Million | -235.73 Million | -650.41 Million | -170.75 Million | -489.7 Million |
Acquisitions | - | - | - | 83.51 Million | - | 47.54 Million |
Investment purchases | - | - | - | -2 Million | - | - |
Sales/Maturities of investments | 67.8 Million | - | - | 6.56 Million | - | - |
Other Investing Activities | -16.13 Million | -9.42 Million | -7.85 Million | -9.8 Million | -4.42 Million | -47.65 Million |
Financing Cash Flow | -144.74 Million | -134.4 Million | -71.94 Million | 421.78 Million | 74.09 Million | -29.26 Million |
Debt repayment | -31.32 Million | -1.77 Billion | -1.63 Billion | -1.47 Billion | -1.34 Billion | -1.24 Billion |
Dividends payments | -113.4 Million | -113.4 Million | -42.52 Million | -56.7 Million | -70.88 Million | -99.23 Million |
Common Stock Repurchased | - | - | - | - | -26 Thousand | -30 Thousand |
Common Stock Issuance | - | - | - | - | 1.48 Billion | 1.31 Billion |
Other Financing Activities | -13 Thousand | 1.74 Billion | 1.6 Billion | 1.95 Billion | -2000.00 | -1000.00 |
Accounts receivables | 226.05 Million | -31.72 Million | -716.09 Million | 154 Thousand | 1.11 Billion | -163.12 Million |
Accounts payables | -1.03 Billion | 954.74 Million | 167.2 Million | -212.82 Million | -1.4 Billion | 453.67 Million |
Inventory | 520.92 Million | -961.78 Million | -68.61 Million | 207.81 Million | 34.27 Million | -417.51 Million |
Other working capital | 156.7 Million | -137.99 Million | 71.62 Million | -305.46 Million | -32.58 Million | -65 Million |
Cash at beginning of period | 973.61 Million | 1.67 Billion | 1.67 Billion | 1.71 Billion | 1.65 Billion | 1.75 Billion |
Cash at end of period | 1 Billion | 1.67 Billion | 1.67 Billion | 1.8 Billion | 1.71 Billion | 1.65 Billion |
Capital Expenditure | -132.4 Million | -320.33 Million | -235.73 Million | -650.41 Million | -170.75 Million | -489.7 Million |
Effect of forex changes on cash | - | - | 139.61 Million | - | - | -30 Thousand |
Net cash flow / Change in cash | 34.06 Million | -465 Thousand | 239 Thousand | 93.84 Million | 59.48 Million | -101 Million |
Free Cash Flow | 127.14 Million | 143.36 Million | -59.57 Million | -406.2 Million | -10.17 Million | -71.59 Million |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 158.73 Million | 165.56 Million | 21.6 Million | -82.08 Million | 435.92 Million | -87.45 Million |
Depreciation & Amortization | 302.7 Million | 75.62 Million | 73.57 Million | 72.84 Million | 311.99 Million | 82.86 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -126.56 Million | - | - | - | -176.75 Million | - |
Other non-cash items | 813.34 Million | -89.94 Million | 51.97 Million | 154.93 Million | -107.46 Million | 170.31 Million |
Investing Cash Flow | -80.74 Million | - | - | - | -329.76 Million | - |
Investments in PPE | -132.4 Million | - | - | - | -320.33 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | 67.8 Million | - | - | - | - | - |
Other Investing Activities | -16.13 Million | - | - | - | -9.42 Million | - |
Financing Cash Flow | -144.74 Million | - | - | - | -134.4 Million | - |
Debt repayment | -31.32 Million | - | - | - | -1.77 Billion | - |
Dividends payments | -113.4 Million | - | - | - | -113.4 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -13 Thousand | - | - | - | 1.74 Billion | - |
Accounts receivables | 226.05 Million | - | - | - | -31.72 Million | - |
Accounts payables | -1.03 Billion | - | - | - | 954.74 Million | - |
Inventory | 520.92 Million | - | - | - | -961.78 Million | - |
Other working capital | 156.7 Million | - | - | - | -137.99 Million | - |
Cash at beginning of period | 973.61 Million | 1.58 Billion | 1.65 Billion | 973.61 Million | 1.67 Billion | 1.64 Billion |
Cash at end of period | 1 Billion | 1.66 Billion | 1.58 Billion | 1.65 Billion | 1.67 Billion | 973.61 Million |
Capital Expenditure | -132.4 Million | - | - | - | -320.33 Million | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 34.06 Million | 82.78 Million | -69.96 Million | 678.81 Million | -465 Thousand | -667.87 Million |
Free Cash Flow | 127.14 Million | 151.25 Million | 147.15 Million | 145.69 Million | 143.36 Million | 165.72 Million |
IXOG
JAV
7971
300323
PWUP
HEALTHYLIFE